HatleyRHM, von HollenD, SandellD, and SlatorL: In vitro characterization of the OptiChamber Diamond Valved Holding Chamber. J Aerosol Med Pulm Drug Deliv., 2014; 27:S24–S36.
2.
OptiChamber Diamond Instructions for Use. Respironics New Jersey Inc., Parsippany, NJ, USA.
3.
AeroChamber Plus Z-Stat Instructions for Use. Monaghan Medical Corporation, Plattsburgh, NY, USA.
4.
Von HollenD, SlatorL, NikanderK, and HatleyRHM: In vitro comparison of aerosol characteristics of three HFA pressurized metered dose inhaler formulations commonly used in asthma using two valved holding chambers. Am J Respir Crit Care Med., 2012; 185:A4240.
5.
SuggettJ, MitchellJ, DoyleC, WangV, and NagelM: Antistatic valved holding chambers do not necessarily offer similar aerosol delivery performance. [Abstract]. Presented at the European Respiratory Society Congress, Barcelona, Spain, September7–11, 2013; Eur Respir J., 42:Suppl 57; 494s DOI: http://www.ersnet.org/learning_resources_player/abstract_print_13/files/Abstract_book_2013.pdf (online only). Last accessed on August29, 2014.
6.
European Medicines Agency/Committee for Medicinal Products for Human Use (CHMP): Guideline on the requirements for clinical documentation for orally inhaled products (OIP) including the requirements for demonstration of therapeutic equivalence between two inhaled products for use in the treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults and for use in the treatment of asthma in children and adolescents. European Medicines Agency. January2009. Available: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003504.pdf. Last accessed on August29, 2014.
